Table 2.

Univariate analysis for the risk of recurrence of HCC after RFA

Parameter	All patients (n = 420)	Patients with recurrence (n = 348)	Patients without recurrence (n = 62)	Univariate hazard ratio (95% confidence interval)	P	Multivariate hazard ratio (95% confidence interval)	P
Age	57.07 ± 9.31	58.32 ± 8.97	55.72 ± 9.52	0.992 (0.927, 1.063)	0.8288	0.992 (0.927, 1.06)	0.8288
Tumor size	32.44 ± 10.64	38.81 ± 9.47	25.49 ± 6.81	1.267 (1.148, 1.398)	0.0001	1.267 (1.148, 1.398)	0.0001
BPC	99.45 ± 59.81	95.05 ± 54.01	104.24 ± 65.46	1.000 (0.992, 1.008)	0.9839	1.000 (0.992, 1.008)	0.9839
BIL	21.05 ± 17.85	22.26 ± 16.58	19.74 ± 19.13	0.981 (0.917, 1.049)	0.5683	0.981 (0.917, 1.049)	0.5683
Albumin	36.91 ± 6.46	35.76 ± 6.14	38.15 ± 6.60	0.998 (0.880, 1.132)	0.974	0.998 (0.880, 1.132)	0.974
PT	14.53 ± 1.98	14.79 ± 2.11	14.24 ± 1.79	1.056 (0.694, 1.608)	0.7988	1.056 (0.694, 1.608)	0.7988
HBV-DNA	3.45 ± 1.77	4.62 ± 1.68	2.18 ± 0.57	7.699 (3.566, 16.625)	0.0001	7.699 (3.566, 16.625)	0.0001
AFP	1.367 ± 1.68	1.95 ± 1.69	0.73 ± 1.72	2.172 (1.256, 3.756)	0.0055	2.172 (1.256, 3.756)	0.0055
AFP response	0.531 ± 0.500	0.514 ± 0.502	0.549 ± 0.500	4.722 (1.053, 21.184)	0.0427	4.722 (1.053, 21.184)	0.0427

BPC blood platelet count, BIL total bilirubin, PT prothrombin time, AFP α-fetoprotein, HBV hepatitis B virus